JC

Jinshan Chen

Pfizer: 6 patents #863 of 5,153Top 20%
BH Bayer Healthcare: 4 patents #2,099 of 8,007Top 30%
Overall (All Time): #450,594 of 4,157,543Top 15%
11
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11312713 Imidazo[4,5-C]quinoline derivatives as LRRK2 inhibitors Michael Aaron Brodney, Thomas Allen Chappie, Jotham Wadsworth Coe, Karen Coffman, Paul Galatsis +14 more 2022-04-26
8809333 Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents Matthew Frank Brown, Michael Joseph Melnick, Justin Ian Montgomery, Usa Reilly 2014-08-19
8748466 Isoxazole derivatives useful as antibacterial agents Joseph Alan Abramite, Matthew Frank Brown, Michael Joseph Melnick, Justin Ian Montgomery, Usa Reilly 2014-06-10
7595325 Substituted pyrrolo[2,3-d]pyrimidine derivatives useful in cancer treatment Matthew Arnold Marx, Susan LaGreca 2009-09-29
7585869 Substituted heterocylces for the treatment of abnormal cell growth Samit Kumar Bhattacharya, Richard Connell, John Charles Kath, Goss S. Kauffman, Blaise S. Lippa +1 more 2009-09-08
7435739 Substituted pyrrolopyrimidines useful in the treatment of cancer Matthew Arnold Marx, Susan LaGreca, Matthew David Wessel 2008-10-14
7271262 Pyrrolopyrimidine derivatives Susan D. La Greca, Joel Arcari, Matthew Arnold Marx, Matthew David Wessel 2007-09-18
6353006 Substituted 2-arylimino heterocycles and compositions containing them, for use as progesterone receptor binding agents Brian R. Dixon, Cedo Martin Bagi, Catherine Brennan, David R. Brittelli, William Bullock +11 more 2002-03-05
6344476 Inhibition of p38 kinase activity by aryl ureas Gerald Ranges, William Scott, Michael Bombara, Deborah Rauner, Aniko Redman +4 more 2002-02-05
5968795 Biaryl acetylenes as inhibitors of matrix metalloproteases Brian R. Dixon 1999-10-19
5932577 Substituted oxobutyric acids as matrix metalloprotease inhibitors Brian R. Dixon, Michael C. VanZandt, David R. Brittelli 1999-08-03